Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PUMP-IT RCT for unresectable synchronous colorectal liver metastases
NL-OMON56934Recruiting
- Sponsor
- Netherlands Cancer Institute
- Start
- Nov 2024
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of floxuridine, fluorouracil, folinic acid, oxaliplatin, irinotecan and 2 more in colorectal cancer (CRC) and colorectal cancer liver metastasis (CRLM) (2 arms), sponsored by Netherlands Cancer Institute. Primary endpoint: overall survival. Started Nov 2024; status: recruiting.
02
Drugs
floxuridinefluorouracilfolinic acidoxaliplatinirinotecan
03
Conditions
colorectal cancer (CRC)colorectal cancer liver metastasis (CRLM)
Beyond the preview
Go deeper on NL-OMON56934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON56934.